title: Topical amikacin formulation induces fibroblast growth factor and cytokine release from human dermal fibroblasts.
authors.affiliation: Istituto di Clinica Dermosifilopatica, Facoltà di Medicina e Chirurgia II Università degli Studi di Napoli, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Baroni
authors.forename: B
authors.initials: B
authors.lastname: Perfetto
authors.forename: G
authors.initials: G
authors.lastname: Buttini
authors.forename: P
authors.initials: P
authors.lastname: Catalanotti
authors.forename: F
authors.initials: F
authors.lastname: Gorga
authors.forename: M A
authors.initials: MA
authors.lastname: Tufano
mesh_terms: D000328:Adult; D000583:Amikacin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D016207:Cytokines / Q000378:metabolism*; D005079:Excipients / Q000494:pharmacology; D005260:Female; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008875:Middle Aged; D012867:Skin / Q000166:cytology*
chemical_list: D000900:Anti-Bacterial Agents; D016207:Cytokines; D005079:Excipients; D006133:Growth Substances; D007375:Interleukin-1; D008070:Lipopolysaccharides; D000583:Amikacin